Developing and testing high-efficacy patient subgroups within a clinical trial using risk scores. (2020)
Attributed to:
Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/sim.8665
PubMed Identifier: 32662542
Publication URI: http://europepmc.org/abstract/MED/32662542
Type: Journal Article/Review
Volume: 39
Parent Publication: Statistics in medicine
Issue: 24
ISSN: 0277-6715